GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PCL Inc (XKRX:241820) » Definitions » Cyclically Adjusted PB Ratio

PCL (XKRX:241820) Cyclically Adjusted PB Ratio : 0.56 (As of Jun. 05, 2025)


View and export this data going back to 2017. Start your Free Trial

What is PCL Cyclically Adjusted PB Ratio?

As of today (2025-06-05), PCL's current share price is ₩302.00. PCL's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₩541.32. PCL's Cyclically Adjusted PB Ratio for today is 0.56.

The historical rank and industry rank for PCL's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:241820' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.56   Med: 0.56   Max: 0.56
Current: 0.56

During the past years, PCL's highest Cyclically Adjusted PB Ratio was 0.56. The lowest was 0.56. And the median was 0.56.

XKRX:241820's Cyclically Adjusted PB Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.87 vs XKRX:241820: 0.56

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

PCL's adjusted book value per share data for the three months ended in Mar. 2025 was ₩117.805. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩541.32 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


PCL Cyclically Adjusted PB Ratio Historical Data

The historical data trend for PCL's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCL Cyclically Adjusted PB Ratio Chart

PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.56

Competitive Comparison of PCL's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, PCL's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PCL's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PCL's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PCL's Cyclically Adjusted PB Ratio falls into.


;
;

PCL Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

PCL's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=302.00/541.32
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PCL's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, PCL's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=117.805/122.5900*122.5900
=117.805

Current CPI (Mar. 2025) = 122.5900.

PCL Quarterly Data

Book Value per Share CPI Adj_Book
201412 -191.320 99.099 -236.672
201509 0.000 100.111 0.000
201512 327.384 100.220 400.457
201603 0.000 100.561 0.000
201606 0.000 100.791 0.000
201609 322.304 101.461 389.422
201612 300.767 101.561 363.042
201703 617.657 102.851 736.200
201706 578.043 102.611 690.590
201709 550.607 103.491 652.223
201712 514.484 102.991 612.391
201803 466.498 104.101 549.352
201806 421.087 104.130 495.735
201809 368.491 105.651 427.573
201812 323.984 104.351 380.613
201903 272.034 104.491 319.154
201906 220.949 104.881 258.256
201909 163.114 105.200 190.077
201912 181.673 105.121 211.863
202003 82.823 105.354 96.373
202006 435.782 105.112 508.245
202009 822.662 106.198 949.646
202012 1,084.118 105.765 1,256.574
202103 687.286 107.357 784.804
202106 126.389 107.579 144.025
202109 403.340 108.759 454.632
202112 417.178 109.676 466.298
202203 612.887 111.848 671.749
202206 1,013.216 114.072 1,088.872
202209 967.727 114.715 1,034.157
202212 784.725 115.179 835.215
202303 575.789 116.507 605.850
202306 472.708 117.182 494.523
202309 747.920 118.964 770.719
202312 688.760 118.837 710.511
202403 753.018 120.123 768.482
202406 836.916 120.007 854.927
202409 841.491 120.861 853.528
202412 120.266 121.135 121.710
202503 117.805 122.590 117.805

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PCL  (XKRX:241820) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


PCL Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of PCL's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PCL Business Description

Traded in Other Exchanges
N/A
Address
Star Valley No. 701, 99, Digitalro, 9gi, Geumcheongu, Seoul, KOR, 08510
PCL Inc is engaged in the development of vitro diagnostics products by SG Cap technology used in immobilizing disease biomarkers. It offers blood testing kit, multiplex antigen detection kits, and ultra-low volume non-contact liquid handling.In addition, the company offers platform services, such as sol-gel spotting service that immobilizes the customer's requested material using the SolB reagent; and SG ID service, which provides customers with a molecule of interest immobilized in the SolB reagent and identified.

PCL Headlines

No Headlines